Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals

PLoS Medicine

Volumn 10, Issue 12, 2013, Pages 1-12

  Riveros, Carolina ^a,b,c   Dechartres, Agnes ^a,b,c   Perrodeau, Elodie ^a,c   Haneef, Romana ^a,c   Boutron, Isabelle ^a,b,c,d   Ravaud, Philippe ^a,b,c,d,e  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

^d French Cochrane Centre   (France)

^e Mailman School of Public Health Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG EFFICACY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HAZARD RATIO; HUMAN; PUBLICATION; PUBLISHING; RESEARCH SUBJECT; SCIENTIFIC LITERATURE; SIDE EFFECT; STUDY DESIGN; TREATMENT OUTCOME; CLINICAL TRIAL (TOPIC); FACTUAL DATABASE; STATISTICS; TIME; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; HUMANS; PUBLISHING; TIME FACTORS; UNITED STATES;

EID: 84892584964     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001566     Document Type: Article

References (38)

1. Chalmers I, Glasziou P, (2009) Avoidable waste in the production and reporting of research evidence. Lancet 374: 86-89.
2. Antes G, Chalmers I, (2003) Under-reporting of clinical trials is unethical. Lancet 361: 978-979.
3. Chalmers I, (1990) Underreporting research is scientific misconduct. JAMA 263: 1405-1408.
4. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR, (1991) Publication bias in clinical research. Lancet 337: 867-872.
5. Liberati A, (2004) An unfinished trip through uncertainties. BMJ 328: 531.
6. Egger M, Smith GD, (1998) Bias in location and selection of studies. BMJ 316: 61-66.
7. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K, (2009) Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009: MR000006.
8. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R, (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358: 252-260.
9. Ioannidis JP, (1998) Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 279: 281-286.
10. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration.
11. Chan AW, Altman DG, (2005) Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 330: 753.
12. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG, (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291: 2457-2465.
13. Chan AW, Krleza-Jeric K, Schmid I, Altman DG, (2004) Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 171: 735-740.
14. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, et al. (2010) The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340: c365.
15. (2007) Food and Drug Administration Amendments Act of 2007. US Public Law 110-85. Washington (District of Columbia): Food and Drug Administration.
16. Clinical trials registries: towards improved access to therapeutic data. Prescrire Int 17: 256-259.
17. Tse T, Williams RJ, Zarin DA, (2009) Reporting "basic results" in ClinicalTrials.gov. Chest 136: 295-303.
18. Tse T, Williams RJ, Zarin DA, (2009) Update on registration of clinical trials in ClinicalTrials.gov. Chest 136: 304-305.
19. R Development Core Team (2011). R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available: http://www.R-project.org/. Accessed 28 October 2013.
20. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM, (2009) Trial publication after registration in ClinicalTrials.gov: a cross-sectional analysis. PLoS Med 6: e1000144 doi:10.1371/journal.pmed.1000144.
21. Huic M, Marusic M, Marusic A, (2011) Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS One 6: e25258 doi:10.1371/journal.pone.0025258.
22. Wieseler B, Kerekes MF, Vervoelgyi V, McGauran N, Kaiser T, (2012) Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications. BMJ 344: d8141.
23. Zarin DA, Ide NC, Tse T, Harlan WR, West JC, et al. (2007) Issues in the registration of clinical trials. JAMA 297: 2112-2120.
24. Zarin DA, Keselman A, (2007) Registering a clinical trial in ClinicalTrials.gov. Chest 131: 909-912.
25. Zarin DA, Tse T, (2008) Medicine. Moving toward transparency of clinical trials. Science 319: 1340-1342.
26. Zarin DA, Tse T, Ide NC, (2005) Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 353: 2779-2787.
27. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, et al. (2012) Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 307: 1838-1847.
28. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC, (2011) The ClinicalTrials.gov results database-update and key issues. N Engl J Med 364: 852-860.
29. Gopal RK, Yamashita TE, Prochazka AV, (2012) Research without results: inadequate public reporting of clinical trial results. Contemp Clin Trials 33: 486-491.
30. Nguyen TA, Dechartres A, Belgherbi S, Ravaud P, (2013) Public availability of results of trials assessing cancer drugs in the United States. J Clin Oncol 31: 2998-3003.
31. Prayle AP, Hurley MN, Smyth AR, (2012) Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 344: d7373.
32. Shamliyan T, (2010) Reporting of results of interventional studies by the information service of the National Institutes of Health. Clin Pharmacol 2: 169-176.
33. Pitrou I, Boutron I, Ahmad N, Ravaud P, (2009) Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med 169: 1756-1761.
34. Mathieu S, Chan AW, Ravaud P, (2013) Use of trial register information during the peer review process. PLoS ONE 8: e59910 doi:10.1371/journal.pone.0059910.
35. Schulz KF, Altman DG, Moher D, (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152: 726-732.
36. Turner L, Shamseer L, Altman DG, Schulz KF, Moher D, (2012) Does use of the CONSORT statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev 1: 60.
37. Ioannidis JPA, Evans SJW, Gøtzsche PC, O'Neill RT, Altman DG, et al. (2004) Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141: 781-788.
38. Reveiz L, Chan A-W, Krleža-Jerić K, Granados CE, Pinart M, et al. (2010) Reporting of methodologic information on trial registries for quality assessment: a study of trial records retrieved from the WHO Search Portal. PLoS One 5: e12484 doi:10.1371/journal.pone.0012484.